COMMUNIQUÉS West-GlobeNewswire

Dans le cadre de la GHE 2024, le KFSHRC célèbre 40 ans de leadership dans le domaine des cellules souches
23/10/2024
Plus de 7 400 greffes de cellules souches ont été réalisées RIYAD, Arabie saoudite, 23 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) a fêté le 40e anniversaire de son [...]
Lung Health Foundation: New Evict Radon National Study Report Underscores ‘Urgent Need for Canada-Wide Advocacy’ to Reduce Dangerous Radon Levels in Canadian Homes
23/10/2024
Canada’s leading lung health organization supports and urges policy reforms through building codes, lung cancer screening and taxation policies TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF [...]
Ancilia Biosciences Selected to Receive $3 Million Award from ARPA-H’s Sprint for Women’s Health
23/10/2024
—Award from Highly Competitive Initiative Will Enable Ancilia to Advance Its Lead Program through IND Filing for Its First Clinical Trial— —Ancilia Also Awarded $274,000 NIH STTR Grant to Expand Its Platform to Diseases [...]
Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health
23/10/2024
DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could change the treatment paradigm for clinical HPV management. Essentially all cervical cancer cases [...]
Saudi Surgeon Honored for Performing the World’s First Fully Robotic Heart Transplant
23/10/2024
"Robotic Heart Surgery" at KFSHRC…A Leading and Accelerating Journey of Success RIYADH, Saudi Arabia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to set [...]
Orchard Therapeutics Announces Multiple Data Presentations and Publications
23/10/2024
Ten presentations at ESGCT 2024 detail the therapeutic potential and applicability of the company’s platform in rare neurometabolic diseases and beyond Nature manuscript highlights clinical results supporting long-term [...]
Le KFSHRC honore 28 scientifiques figurant sur la liste de Stanford des 2 % des chercheurs les plus cités
23/10/2024
En présence d’une large participation de leaders et d’experts du secteur de la santé du monde entier RIYAD, Arabie saoudite, 23 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre ( [...]
BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference
23/10/2024
October 23, 2024 News Release BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference COPENHAGEN, Denmark and BOSTON, MA, USA, October 23, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto [...]
Rapafusyn Announces an Upcoming Oral Presentation at Targeted Protein Degradation & Induced Proximity Summit
23/10/2024
BALTIMORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals is pleased to announce an upcoming oral presentation at the 7 th Targeted Protein Degradation & Induced Proximity Summit taking place from [...]
Le KFSHRC s’impose comme le plus important programme de transplantation rénale par don croisé au monde, avec 500 transplantations réussies
23/10/2024
Le centre consolide son rôle de leader en tant que fournisseur de solutions innovantes pour les patients atteints d’insuffisance rénale RIYAD, Arabie saoudite, 23 oct. 2024 (GLOBE NEWSWIRE) -- Dans le cadre de son [...]
KFSHRC Performs World First Robotic Left Liver Lobe Transplant
23/10/2024
Novel Technique Hopes to Extend Robotic Transplant to More Patients RIYADH, Saudi Arabia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) has achieved another world first [...]
Bloo Pharmapeutica Introduces Age-Defying Methylene Blue Bath Solution: Aqua Miraculorum “Water of Miracles”
23/10/2024
Serious Help for Aging Skin, Now Available Online and in Select Retailers Vancouver, B.C., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Bloo Pharmapeutica Inc. , an innovator in science-based health and wellness solutions, is [...]
HiberCell Receives FDA Fast Track Designation for HC-7366 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML)
23/10/2024
BOSTON, Oct. 23, 2024 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address advanced cancer and cancer resistance, is pleased to announce that the U.S. Food and [...]
Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium
23/10/2024
- Interim data for fadraciclib monotherapy in patients with advanced solid tumors preselected for CDKN2A and/or CDKN2B abnormalities - BERKELEY HEIGHTS, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, [...]
Humber River Health Embarks on $100 Million Fundraising Mission to Cure Healthcare
23/10/2024
Funding to support blueprint for new high-quality, innovative models of care in Canada and beyond TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Canadians take great pride in their universal healthcare system, but with [...]
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
23/10/2024
GLEN ALLEN, Va., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]
Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
23/10/2024
SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
Topline Results from Alkeus Pharmaceuticals’ Study of Oral Gildeuretinol Demonstrate Significant Trend in Slowing GA Progression and Visual Function Improvement
23/10/2024
Oral gildeuretinol demonstrated a statistically significant reduction in the geographic atrophy (GA) lesion growth rate of 15.3% from 6 to 24 months (p=0.047) in a pre-specified analysis. Gildeuretinol is the first [...]
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
23/10/2024
ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial [...]

Pages